INSTITUTION'S PROFILE
PEPP-Montreal, Douglas Research Centre, Montreal, Quebec, Canada.
Publications (1)
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.
Journal: Schizophrenia bulletin
Publication date:
Journal: Schizophrenia bulletin
Publication Year: